Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine
Preprint
Abstract
With the evidence of waning immunity of the BNT162b2 vaccine, a national third dose vaccination campaign was initiated in Israel during August 2021; other countries have announced their intention to administer a booster shot as well. Leveraging data from Maccabi Healthcare Services, we conducted a preliminary retrospective study aimed at evaluating initial short-term effectiveness of a three dose versus a two dose regimen against infection due to the Delta variant of SARS-CoV-2, using two complementary approaches; a test-negative design and a matched case-control design. We found that 7-13 days after the booster shot there is a 48-68% reduction in the odds of testing positive for SARS-CoV-2 infection and that 14-20 days after the booster the marginal effectiveness increases to 70-84%. Further studies are needed to determine the duration of protection conferred by the third dose and its effect on severe disease.Keywords
All Related Versions
- Published version: JAMA Internal Medicine, 182 (2), 179.
This publication has 17 references indexed in Scilit:
- Durability of SARS-CoV-2 IgG Antibody Among Residents in a Long-Term Care CommunityJournal of the American Medical Directors Association, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- A case-control and cohort study to determine the relationship between ethnic background and severe COVID-19eClinicalMedicine, 2020
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humansNature Microbiology, 2020
- Test-Negative DesignsEpidemiology, 2019
- Prevalence and Factors Associated With Resistant Hypertension in a Large Health Maintenance Organization in IsraelHypertension, 2014
- Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and MortalityJAMA, 2014
- The use of an automated patient registry to manage and monitor cardiovascular conditions and related outcomes in a large health organizationInternational Journal of Cardiology, 2011
- Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposureBMC Medical Research Methodology, 2005
- The epidemiology of diabetes in a large Israeli HMOEuropean Journal of Epidemiology, 2003